Under construction – not a live service
Sign in
Not yet taking people in IndonesiaNo phase

Channa striata and Curcuma supplement for patients with breast cancer

Tests a fish and turmeric supplement against placebo in people with breast cancer.

Key facts

Who runs it
DINA KEUMALA SARI
Where
Medan, IndonesiaSee the site
Trial code
Registry title
The Effect of Channa Striata and Curcuma Supplementation on Nutritional Status, Interleukin-6 Levels, and Quality of Life in Patients With Breast Cancer.
Status
Not yet recruiting
People taking part
76 people, planned
Started
1 Aug 2026
Expected to end
31 Jan 2027
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • channa striata and curcuma
  • Maltodextrin (Placebo)
Record updated
23 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women with breast cancer who are having chemotherapy, can eat by mouth and have low blood albumin.

Age
18 years or older
Sex
Women only
Disease stage
Breast cancer, currently having chemotherapy
Earlier treatment
Must be receiving chemotherapy for breast cancer now. Must not take other protein or amino acid supplements during the study.
Biomarker or test result
Serum albumin level of 2.0-3.5 g/dL; body mass index (BMI) of 18-29 kg/m²

Main reasons for not taking part

  • Chronic kidney disease, kidney failure or kidney infection
  • Known allergy to fish or Channa striata (snakehead fish) albumin products
  • Taking other protein or amino acid supplements during the study
  • Not following the plan or stopping the supplement before the study ends

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Female patients with breast cancer aged ≥18 years who were undergoing chemotherapy
  • Patients with a body mass index (BMI) of 18-29 kg/m²
  • Patients currently receiving chemotherapy for breast cancer
  • Patients with serum albumin levels of 2.0-3.5 g/dL
  • Patients who were able to consume oral food and were willing to participate in the study by providing written informed consent

Who cannot take part

  • Patients receiving other protein or amino acid supplements during the study period
  • Patients with chronic kidney disease, renal failure, or kidney infection
  • Patients with a known allergy to fish or Channa striata (snakehead fish) albumin-derived products
  • Patients who were non-compliant or discontinued the intervention before completion of the study

Where in Indonesia

  • Nutrition DepartmentMedan, IndonesiaContact: Damayanti Tridah AyuNo longer taking part

About the trial

What the trial wants to find out

Breast cancer is frequently accompanied by chronic inflammation, malnutrition, and reduced quality of life, all of which may compromise treatment response and clinical outcomes. Nutritional interventions with immunomodulatory and anti-inflammatory properties have the potential to improve these conditions. Channa striata is rich in high-quality protein, albumin, and essential amino acids that support nutritional recovery and tissue repair, while Curcuma contains curcumin, a bioactive compound with well-established anti-inflammatory and antioxidant effects. This study aims to evaluate the effect of combined Channa striata and Curcuma supplementation on nutritional status, serum interleukin-6 (IL-6) levels, and quality of life in patients with breast cancer undergoing treatment. The findings are expected to provide evidence for the use of this nutritional supplementation as a complementary strategy to improve clinical outcomes, reduce systemic inflammation, and enhance the overall well-being of breast cancer patients.

The 2 groups in the trial

  • experimental : channa striata and curcumaTreatment being tested

    intervention group

    Treatment: channa striata and curcuma

  • controlPlacebo, for comparison

    control group

    Treatment: Maltodextrin (Placebo)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
The Effect of Channa Striata and Curcuma Supplementation on Nutritional Status, Interleukin-6 Levels, and Quality of Life in Patients With Breast Cancer.
Plain-language title
Channa striata and Curcuma supplement for patients with breast cancerGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 13 November 2026.
Record updated
23 July 2026